Capital Asset Advisory Services LLC Ascendis Pharma A/S Transaction History

Capital Asset Advisory Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$127.1 - $169.66 $437,605 - $584,139	-3,443 Closed	0 $0
Q3 2021 Oct 14, 2021	SELL	$112.67 - $176.92 $6,196 - $9,730	-55 Reduced 1.57%	3,443 $549,000
Q2 2021 Aug 06, 2021	BUY	$121.62 - $145.29 $18,486 - $22,084	152 Added 4.54%	3,498 $460,000
Q1 2021 May 13, 2021	BUY	$124.92 - $173.33 $99,186 - $137,624	794 Added 31.11%	3,346 $431,000
Q4 2020 Mar 02, 2021	BUY	$151.2 - $182.76 $117,179 - $141,639	775 Added 43.61%	2,552 $426,000
Q3 2020 Nov 18, 2020	SELL	$134.29 - $154.32 $1,611 - $1,851	-12 Reduced 0.67%	1,777 $274,000
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $26,608 - $37,442	240 Added 15.49%	1,789 $251,000
Q1 2020 May 18, 2020	BUY	$97.01 - $145.11 $150,268 - $224,775	1,549 New	1,549 $208,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Asset Advisory Services LLC with notifications on news.